BRPI0912253A2 - granulado compreendendo oxalato de escitalopram. - Google Patents
granulado compreendendo oxalato de escitalopram.Info
- Publication number
- BRPI0912253A2 BRPI0912253A2 BRPI0912253A BRPI0912253A BRPI0912253A2 BR PI0912253 A2 BRPI0912253 A2 BR PI0912253A2 BR PI0912253 A BRPI0912253 A BR PI0912253A BR PI0912253 A BRPI0912253 A BR PI0912253A BR PI0912253 A2 BRPI0912253 A2 BR PI0912253A2
- Authority
- BR
- Brazil
- Prior art keywords
- granules
- escitalopram oxalate
- escitalopram
- oxalate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08008614A EP2116231A1 (en) | 2008-05-07 | 2008-05-07 | Granulate comprising escitalopram oxalate |
PCT/EP2009/003214 WO2009135649A1 (en) | 2008-05-07 | 2009-05-05 | Granulate comprising escitalopram oxalate |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0912253A2 true BRPI0912253A2 (pt) | 2015-10-06 |
Family
ID=39731669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0912253A BRPI0912253A2 (pt) | 2008-05-07 | 2009-05-05 | granulado compreendendo oxalato de escitalopram. |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP2116231A1 (pt) |
JP (1) | JP5575114B2 (pt) |
CN (1) | CN102026626B (pt) |
AU (1) | AU2009243734B2 (pt) |
BR (1) | BRPI0912253A2 (pt) |
CA (1) | CA2722802C (pt) |
EA (1) | EA201001740A1 (pt) |
WO (1) | WO2009135649A1 (pt) |
ZA (1) | ZA201007554B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20120448A1 (it) | 2012-01-30 | 2013-07-31 | Carthesia Sas | Composizione liofilizzata di escitalopram ossalato per somministrazione sublinguale |
CN104523638B (zh) * | 2014-11-28 | 2020-02-21 | 浙江华海药业股份有限公司 | 含有草酸艾司西酞普兰的片剂及其制备方法 |
WO2018190294A1 (ja) * | 2017-04-10 | 2018-10-18 | 東和薬品株式会社 | エスシタロプラム医薬組成物 |
CN107441053A (zh) * | 2017-06-21 | 2017-12-08 | 山东京卫制药有限公司 | 一种草酸艾司西酞普兰片的制备方法 |
JP7453859B2 (ja) | 2020-06-22 | 2024-03-21 | 東和薬品株式会社 | エスシタロプラム錠剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1526331A (en) | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
GB8814057D0 (en) | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
RS8304A (en) | 2001-07-31 | 2006-12-15 | H.Lundbeck A/S. | Crystalline composition containing escitalopram |
EA200601641A1 (ru) * | 2004-03-05 | 2006-12-29 | Х. Лундбекк А/С | Кристаллическая композиция, содержащая оксалат эсциталопрама |
WO2006123243A2 (en) * | 2005-05-20 | 2006-11-23 | Aurobindo Pharma Limited | Pharmaceutical dosage forms comprising escitalopram in form of granules |
WO2008046617A1 (en) * | 2006-10-20 | 2008-04-24 | Ratiopharm Gmbh | Escitalopram and solid pharmaceutical composition comprising the same |
-
2008
- 2008-05-07 EP EP08008614A patent/EP2116231A1/en not_active Withdrawn
-
2009
- 2009-05-05 EP EP09741868A patent/EP2276466A1/en not_active Withdrawn
- 2009-05-05 AU AU2009243734A patent/AU2009243734B2/en not_active Ceased
- 2009-05-05 BR BRPI0912253A patent/BRPI0912253A2/pt active Search and Examination
- 2009-05-05 JP JP2011507826A patent/JP5575114B2/ja not_active Expired - Fee Related
- 2009-05-05 CN CN2009801163304A patent/CN102026626B/zh not_active Expired - Fee Related
- 2009-05-05 CA CA2722802A patent/CA2722802C/en not_active Expired - Fee Related
- 2009-05-05 WO PCT/EP2009/003214 patent/WO2009135649A1/en active Application Filing
- 2009-05-05 EA EA201001740A patent/EA201001740A1/ru unknown
-
2010
- 2010-10-22 ZA ZA2010/07554A patent/ZA201007554B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2009243734B2 (en) | 2014-02-27 |
JP2011520798A (ja) | 2011-07-21 |
WO2009135649A1 (en) | 2009-11-12 |
EA201001740A1 (ru) | 2011-06-30 |
CN102026626B (zh) | 2013-01-09 |
ZA201007554B (en) | 2012-01-25 |
CN102026626A (zh) | 2011-04-20 |
CA2722802A1 (en) | 2009-11-12 |
CA2722802C (en) | 2016-06-07 |
EP2276466A1 (en) | 2011-01-26 |
AU2009243734A1 (en) | 2009-11-12 |
EP2116231A1 (en) | 2009-11-11 |
JP5575114B2 (ja) | 2014-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2021006I1 (no) | Quofenix, delafloksacin | |
BRPI0815717A2 (pt) | Compostos de imidazopirazina. | |
BRPI0911616A2 (pt) | acesso de menu utilizando operação de arrastar. | |
BRPI0813235A2 (pt) | Combinação anti-helmíntica. | |
CL2007002263S1 (es) | Motoneta. | |
IT1392848B1 (it) | Motociclo. | |
BRPI0922005A2 (pt) | composições antiespumantes. | |
BRPI0907925A2 (pt) | Ativadores de glicoquinase. | |
CL2008000457S1 (es) | Motoneta. | |
FR2930460B1 (fr) | Distributeur de fragrance. | |
ATE527260T1 (de) | (dihydro)pyrroloä2,1-aüisoquinoline | |
IT1393170B1 (it) | Dispositivo di controllo di contropunta. | |
IT1396406B1 (it) | Stantuffo. | |
CL2007003097S1 (es) | Motocicleta. | |
BRPI0912716A2 (pt) | composto. | |
IT1393579B1 (it) | Motociclo. | |
NL1031397A1 (nl) | Samenstelling omvattende desmopressine. | |
BRPI0912253A2 (pt) | granulado compreendendo oxalato de escitalopram. | |
BRPI0924638A2 (pt) | ativação de função. | |
BRPI0912331A2 (pt) | distribuidor. | |
BRPI0917366A2 (pt) | sistema de indexação. | |
BRPI1014244A2 (pt) | composto de polipropileno-talco estabilizado. | |
IT1396642B1 (it) | Statore. | |
BRPI1011720A2 (pt) | compostos de 1,1,1- tri-flúor-2 hidróxi-propila. | |
FR2935945B1 (fr) | Installation de telepherique. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B08F | Application fees: dismissal - article 86 of industrial property law | ||
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) | ||
B07E | Notice of approval relating to section 229 industrial property law |